Instil Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-156.09	-223.18	-156.79	-37.74	-6.52
Depreciation & Amortization	5.4	7.75	2.75	0.26	0.02
Share-Based Compensation	18.17	30.44	26.2	1.71	0.29
Other Operating Activities	50.5	4.82	5.71	6.16	0.92
Operating Cash Flow	-82.03	-180.16	-122.14	-29.62	-5.29
Capital Expenditures	-20.66	-84.59	-57.83	-50.82	-0.21
Acquisitions	1.56	0	0	-0.31	0
Change in Investments	60.23	199.13	-416.57	0	0
Other Investing Activities	-	-	-	-	-0.55
Investing Cash Flow	41.13	114.54	-474.4	-51.12	-0.76
Share Issuance / Repurchase	0	1.55	340.77	0.37	0
Debt Issued / Paid	8.08	70.34	0	0	0
Other Financing Activities	-	-	52.39	312.68	14.95
Financing Cash Flow	8.08	71.89	393.16	313.05	14.95
Exchange Rate Effect	-0.2	-0.64	-0.3	0.56	0
Net Cash Flow	-32.82	6.26	-203.37	232.31	8.9
Free Cash Flow	-102.69	-264.75	-179.97	-80.43	-5.5
Free Cash Flow Margin	-	-	-	-58284.06%	-
Free Cash Flow Per Share	-15.79	-40.88	-33.96	-100.55	-9.29

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).